T.P. MAKAROVA, G.R. DAVLETBAEVA, L.V. PОLADOVA, N.V. OSIPOVA, Yu.S. MELNIKOVA
Kazan State Medical University
Children’s Republican Clinical Hospital

Makarova Tamara Petrovna
Doctor of Medical Science, Professor at the Department of Hospital Pediatrics
49 Butlerova Str., Kazan 420012
tel. (843) 237-30-37, e-mail: [email protected] 

The article contains the results of a clinical supervision of a patient with atypical hemolytic uremic syndrome, receiving therapy with Еculizumab. The clinical characteristics of the disease and the dynamics of laboratory data in the course of treatment is given.

Key words: аtypical hemolytic uremic syndrome, plasmotherapy, hemodialysis, eculizumab, clinical case.

 

 

REFERENCES

1. Popa A.V., Lifshic V.I., Jemirova H.M., Abaseeva T.Ju. i dr. Sovremennye predstavlenija ob atipichnom gemolitiko-uremicheskom sindrome (NON-Stx-HUS) // Pediatrija. — 2011. — T. 90, № 4. — S. 134-140.

2. Makarova T.P., Jemirova H.M., Zverev D.V., Osipova N.V. Atipichnyj gemolitiko-uremicheskij sindrom u detej // Prakticheskaja medicina. — 2012. — №7 (62). — S. 57-61.

3. Loirat C., Noris M., Fremeaux-Bacchi V. Complement and the atypical hemolytic uremic syndrome // Pediatr Nephrol. — 2008. — Vol. 23. — R. 1957-1972.

4. Ariceta G., Besbas N., Johnson S., Karpman D. et al. Guidelines for the investigation and initial therapy of diarrhea negative haemolytic uraemic syndrome // Pediatr Nephrol. — 2009. — Vol. 24. — R. 687-696.

5. Taylor C.M., Machin S., Wigmore S.J., Goodship T.H. Clinical Practice Guidelines for the management of atypical Haemolytic Uraemic Syndrome in the United Kingdom // Br J Haematol. — 2010. — 148. — R. 37-7